IMCD N.V. (IMCD.AS)
| Previous close | 149.00 |
| Open | 136.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 133.90 - 145.00 |
| 52-week range | 109.05 - 169.05 |
| Volume | |
| Avg. volume | 109,211 |
| Market cap | 8.066B |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | 27.62 |
| EPS (TTM) | 5.13 |
| Earnings date | 26 Apr 2024 |
| Forward dividend & yield | 2.24 (1.50%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | 155.50 |
GlobeNewswireIMCD reports EBITA of EUR 127 million in the first three months of 2024
IMCD_logo Logo IMCD Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first three months 2024 results. HIGHLIGHTS Gross profit of EUR 295 million (on a constant currency basis, equal to the first three months of 2023)Operating EBITA decline of 15% to EUR 127 million (-13% on a constant currency basis)Free cash flow of EUR 106 million (first three months o
GlobeNewswireIMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
Photo_IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma Photographed from left to right:•Cristina Marti, Director API Sales and Strategy, IMCD Group•Gianluca Galimberti, General Manager, Cobapharma•Tess Hendriks, Legal Counsel M&A, IMCD Group•Fenna van Zanten, Director M&A, IMCD Group•Jose Alcover, Managing Director, IMCD Iberia & Maghreb ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and
Simply Wall St.IMCD N.V.'s (AMS:IMCD) Stock Has Fared Decently: Is the Market Following Strong Financials?
Most readers would already know that IMCD's (AMS:IMCD) stock increased by 9.5% over the past three months. Given that...
